GlassScriptPhysician profile
Timothy James Alikakos
NPI 1427043223
$9,209.90
in general payments reported to CMS, 2019-2025
34 companies · $1,250 in 2025
The $1,250 reported for 2025 was more than what 75% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $730 · 2021: $557 · 2022: $1,208 · 2023: $714 · 2024: $4,752 · 2025: $1,250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,499 · Food and Beverage: $3,216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,499.44 |
| Food and Beverage | $3,216.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,114.39 | 2020-2025 | Versacross Access Solution, Watchman Flx, Watchman Access System |
| Novartis Pharmaceuticals Corporation | $921.08 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $495.45 | 2020-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $465.23 | 2020-2025 | Camzyos, Eliquis |
| Medtronic, INC. | $459.11 | 2021-2025 | Micra, Linq II |
| Abbott Laboratories | $347.36 | 2020-2025 | Optis, Diamondback Coronary, Coroflow |
| Astellas Pharma US INC | $242.68 | 2020-2023 | Lexiscan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $226.58 | 2020-2025 | Jardiance |
| Amarin Pharma, INC. | $171.79 | 2020-2022 | |
| Edwards Lifesciences Corporation | $159.22 | 2022-2025 | Sapien 3 Ultra Resilia |
| Cvrx, INC. | $156.38 | 2024-2025 | Barostim Neo System |
| Merck Sharp & Dohme LLC | $153.64 | 2021-2025 | Verquvo, Capvaxive |
| Inari Medical, INC. | $145.06 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cardiva Medical, INC. | $118.49 | 2024-2025 | Optowire, Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Amgen INC. | $112.21 | 2020-2025 | Repatha, Repatha |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $95.06 | 2020-2022 | |
| Biotronik INC. | $86.11 | 2020-2025 | Acticor 7 Vr-T Dx |
| Bayer Healthcare Pharmaceuticals INC. | $73.84 | 2021-2025 | |
| Abiomed | $68.65 | 2025 | |
| Philips North America LLC | $67.77 | 2023-2025 | Ecc Solutions, Ambulatory Monitoring & Diagnostics Undivided |
| Impulse Dynamics (USA) INC. | $64.59 | 2023 | Optimizer |
| Ge Healthcare | $62.34 | 2020 | |
| Atricure, INC. | $57.95 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Esperion Therapeutics, INC. | $54.72 | 2020-2023 | Nexletol |
| Bard Peripheral Vascular, INC. | $43.58 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $41.33 | 2020-2025 | Lifevest |
| Irhythm Technologies, INC. | $41.22 | 2024 | Zio Monitor, Zio Xt Patch |
| Cardiovascular Systems INC. | $30.20 | 2021-2022 | |
| Cardinal Health 200 LLC | $27.08 | 2020 | |
| Scpharmaceuticals INC. | $26.46 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $25.61 | 2020 | |
| Alnylam Pharmaceuticals INC. | $24.12 | 2022 | |
| Akcea Therapeutics, INC. | $19.15 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $11.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Alikakos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.